Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Apr;48(4):287–290. doi: 10.1136/jcp.48.4.287

Clinicopathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients.

J A Thomas 1, D H Crawford 1, M Burke 1
PMCID: PMC502541  PMID: 7615843

Full text

PDF
287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. M., Kormos R. L., Stuart R. S., Fricker F. J., Griffith B. P., Nalesnik M., Hardesty R. L., Dummer J. S. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991 Nov-Dec;10(6):877–887. [PubMed] [Google Scholar]
  2. Cen H., Williams P. A., McWilliams H. P., Breinig M. C., Ho M., McKnight J. L. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood. 1993 Mar 1;81(5):1393–1403. [PubMed] [Google Scholar]
  3. Hanto D. W., Frizzera G., Gajl-Peczalska K. J., Simmons R. L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation. 1985 May;39(5):461–472. doi: 10.1097/00007890-198505000-00001. [DOI] [PubMed] [Google Scholar]
  4. Locker J., Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol. 1989 Dec;135(6):977–987. [PMC free article] [PubMed] [Google Scholar]
  5. Nalesnik M. A., Jaffe R., Starzl T. E., Demetris A. J., Porter K., Burnham J. A., Makowka L., Ho M., Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988 Oct;133(1):173–192. [PMC free article] [PubMed] [Google Scholar]
  6. Patton D. F., Wilkowski C. W., Hanson C. A., Shapiro R., Gajl-Peczalska K. J., Filipovich A. H., McClain K. L. Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease. Transplantation. 1990 Jun;49(6):1080–1084. doi: 10.1097/00007890-199006000-00010. [DOI] [PubMed] [Google Scholar]
  7. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc. 1991 Feb;23(1 Pt 2):1101–1103. [PubMed] [Google Scholar]
  8. Randhawa P. S., Markin R. S., Starzl T. E., Demetris A. J. Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol. 1990 Jun;14(6):538–547. doi: 10.1097/00000478-199006000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Thomas J. A., Hotchin N. A., Allday M. J., Amlot P., Rose M., Yacoub M., Crawford D. H. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation. 1990 May;49(5):944–953. doi: 10.1097/00007890-199005000-00022. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES